Form 4: PAVM: Insider Granted Restricted Stock

Victoria Tou-ho Lee, Chief Medical Officer of PAVmed Inc., was granted 70,000 shares of restricted stock.

Summary

• Victoria Tou-ho Lee, Chief Medical Officer of PAVmed Inc. (PAVM), received a grant of 70,000 shares of common stock.
• This grant is part of the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan.
• The restricted stock has a single vesting date of May 20, 2029, and is subject to forfeiture if the service period is not completed.
• The transaction date was April 2, 2026, and the reported acquisition price was $0.
• Following this transaction, Ms. Lee beneficially owns 71,666 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation event (restricted stock grant) rather than a significant financial or strategic development for the company.

Positives

• Grant of 70,000 restricted shares to a key executive (Chief Medical Officer) indicates a long-term incentive and retention strategy.
• The grant is part of an established equity incentive plan, suggesting a structured approach to compensation.
• The executive's continued involvement is secured through a vesting schedule tied to service completion.

Negatives

• The restricted stock is subject to forfeiture if the requisite service period is not completed, posing a risk to the executive's potential ownership.
• The acquisition price of $0 for the restricted stock means no immediate capital was invested by the executive for this portion of their compensation.

Risks

• Forfeiture of restricted stock if the requisite service period is not completed by May 20, 2029.
• Potential for dilution to existing shareholders if a large number of equity grants are issued.
• The value of the restricted stock is subject to the future performance and stock price of PAVmed Inc.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. The vesting schedule for the restricted stock extends to May 20, 2029, implying a long-term outlook for the executive's role and commitment.

Management Comments

• The grant represents restricted stock granted under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan.
• The restricted stock is subject to forfeiture if the requisite service period is not completed.

Industry Context

StockSavvy.ai notes that equity grants to key executives, such as Chief Medical Officers, are a common practice in the healthcare and biotechnology sectors to align executive interests with long-term company performance and shareholder value.

Related Party Transactions

• Grant of 70,000 restricted shares to Victoria Tou-ho Lee, Chief Medical Officer, under the company's Long-Term Incentive Equity Plan.

Stakeholder Impact

• Shareholders: The grant represents a form of compensation that could lead to dilution if a large number of such grants are issued. However, it also signals a commitment from a key executive.
• Employees: May be impacted by the company's overall compensation strategy and the potential for future equity grants.
• Management: Reinforces the use of equity as a tool for executive retention and motivation.

Next Steps

• Ms. Lee must complete the requisite service period to vest in the 70,000 shares of restricted stock by May 20, 2029.
• The company will continue to operate under its Long-Term Incentive Equity Plan for executive compensation.

Key Dates

Keywords

PAVM, PAVmed Inc., Form 4, Insider Transaction, Restricted Stock, Equity Grant, Executive Compensation, Chief Medical Officer, Vesting Schedule, Securities Exchange Act